These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26178648)

  • 1. Understanding peptide competitive inhibition of botulinum neurotoxin A binding to SV2 protein via molecular dynamics simulations.
    Chang S; He HQ; Shen L; Wan H
    Biopolymers; 2015 Oct; 103(10):597-608. PubMed ID: 26178648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics simulations of wild type and mutants of botulinum neurotoxin A complexed with synaptic vesicle protein 2C.
    Wang F; Wan H; Hu JP; Chang S
    Mol Biosyst; 2015 Jan; 11(1):223-31. PubMed ID: 25358067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin.
    Weisemann J; Stern D; Mahrhold S; Dorner BG; Rummel A
    Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27196927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding.
    Gustafsson R; Zhang S; Masuyer G; Dong M; Stenmark P
    Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29649119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the BoNT/A2 receptor-binding domain in complex with the luminal domain of its neuronal receptor SV2C.
    Benoit RM; Schärer MA; Wieser MM; Li X; Frey D; Kammerer RA
    Sci Rep; 2017 Mar; 7():43588. PubMed ID: 28252640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A.
    Benoit RM; Frey D; Hilbert M; Kevenaar JT; Wieser MM; Stirnimann CU; McMillan D; Ceska T; Lebon F; Jaussi R; Steinmetz MO; Schertler GF; Hoogenraad CC; Capitani G; Kammerer RA
    Nature; 2014 Jan; 505(7481):108-11. PubMed ID: 24240280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Only the complex N559-glycan in the synaptic vesicle glycoprotein 2C mediates high affinity binding to botulinum neurotoxin serotype A1.
    Mahrhold S; Bergström T; Stern D; Dorner BG; Åstot C; Rummel A
    Biochem J; 2016 Sep; 473(17):2645-54. PubMed ID: 27313224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of botulinum neurotoxin serotype A1 binding to human SV2A or SV2C receptors.
    Azzaz F; Hilaire D; Fantini J
    Chem Biol Interact; 2023 Mar; 373():110384. PubMed ID: 36754227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights into the interaction of botulinum neurotoxin a with its neuronal receptor SV2C.
    Li X; Brunner C; Wu Y; Leka O; Schneider G; Kammerer RA
    Toxicon; 2020 Feb; 175():36-43. PubMed ID: 31783045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron-recognizable characteristics of peptides recombined using a neuronal binding domain of botulinum neurotoxin.
    Kim HR; Jung Y; Shin J; Park M; Kweon DH; Ban C
    Sci Rep; 2022 Mar; 12(1):4980. PubMed ID: 35322139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SV2 is the protein receptor for botulinum neurotoxin A.
    Dong M; Yeh F; Tepp WH; Dean C; Johnson EA; Janz R; Chapman ER
    Science; 2006 Apr; 312(5773):592-6. PubMed ID: 16543415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the BoNT/A1--receptor complex.
    Benoit RM; Frey D; Wieser MM; Thieltges KM; Jaussi R; Capitani G; Kammerer RA
    Toxicon; 2015 Dec; 107(Pt A):25-31. PubMed ID: 26260692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A.
    Yao G; Zhang S; Mahrhold S; Lam KH; Stern D; Bagramyan K; Perry K; Kalkum M; Rummel A; Dong M; Jin R
    Nat Struct Mol Biol; 2016 Jul; 23(7):656-62. PubMed ID: 27294781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum neurotoxins: new questions arising from structural biology.
    Kammerer RA; Benoit RM
    Trends Biochem Sci; 2014 Nov; 39(11):517-26. PubMed ID: 25282537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves.
    Mahrhold S; Rummel A; Bigalke H; Davletov B; Binz T
    FEBS Lett; 2006 Apr; 580(8):2011-4. PubMed ID: 16545378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
    Fu Z; Chen C; Barbieri JT; Kim JJ; Baldwin MR
    Biochemistry; 2009 Jun; 48(24):5631-41. PubMed ID: 19476346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
    Baldwin MR; Barbieri JT
    Biochemistry; 2007 Mar; 46(11):3200-10. PubMed ID: 17311420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative role of neurotoxin-associated proteins in the structural stability and endopeptidase activity of botulinum neurotoxin complex types A and E.
    Kukreja RV; Singh BR
    Biochemistry; 2007 Dec; 46(49):14316-24. PubMed ID: 18004882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
    Peng L; Tepp WH; Johnson EA; Dong M
    PLoS Pathog; 2011 Mar; 7(3):e1002008. PubMed ID: 21483489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational analysis of GT1B ganglioside and its interaction with botulinum neurotoxin type B: a study by molecular modeling and molecular dynamics.
    Venkateshwari S; Veluraja K
    J Biomol Struct Dyn; 2012; 30(3):255-68. PubMed ID: 22746533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.